2023
DOI: 10.1016/j.crneur.2022.100072
|View full text |Cite
|
Sign up to set email alerts
|

The use of chemogenetic actuator ligands in nonhuman primate DREADDs-fMRI

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
3

Relationship

2
5

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 96 publications
0
7
0
Order By: Relevance
“…Throughout this study, we used DCZ, a recently validated compound (Nagai et al, 2020) to activate the inhibitory DREADD receptors. This actuator is highly selective for DREADD receptors and enables precision targeting without concern for off-target effects on behavior or whole-brain functional connectivity (Upright and Baxter, 2020; Fujimoto et al, 2022; Cushnie et al, 2023). However, much of the initial and current research incorporating DREADDs uses clozapine-N-oxide (CNO; Armbruster et al, 2007; Grayson et al, 2016).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Throughout this study, we used DCZ, a recently validated compound (Nagai et al, 2020) to activate the inhibitory DREADD receptors. This actuator is highly selective for DREADD receptors and enables precision targeting without concern for off-target effects on behavior or whole-brain functional connectivity (Upright and Baxter, 2020; Fujimoto et al, 2022; Cushnie et al, 2023). However, much of the initial and current research incorporating DREADDs uses clozapine-N-oxide (CNO; Armbruster et al, 2007; Grayson et al, 2016).…”
Section: Resultsmentioning
confidence: 99%
“…To aid selective manipulation of DREADD-expressing cells and assess the causal influence of their projections across the brain, we used deschloroclozapine (DCZ). This actuating drug is proven to be inert and has no effect on whole-brain functional connectivity (Fujimoto et al, 2022; Cushnie et al, 2023) or on various types of behaviors (Nagai et al, 2020; Upright and Baxter, 2020; Mimura et al, 2021). DREADD-mediated inhibition of the amygdala increased the brain-wide rs-FC of this area, and specifically increased rs-FC between amygdala and frontal cortex.…”
Section: Introductionmentioning
confidence: 99%
“…This might be a result of task-relevant cortical activity emerging, or remaining during the fixation period 21 . To estimate neural timescales at “rest”, work in anesthetized subjects or during sleep might be a viable alternative 9 , 38 , 39 , although these approaches come with their own disadvantages and confounds. We have previously shown that neural timescales estimated from fMRI data in anesthetized nonhuman primates replicated hierarchies derived from neuronal spiking data, although they did not perfectly match 9 .…”
Section: Discussionmentioning
confidence: 99%
“…This might be a result of task-relevant cortical activity emerging or remaining during the fixation period. To estimate neural timescales at “rest”, work in anesthetized subjects or during sleep might be a viable alternative (for example, see Cushnie et al, 2023; Manea et al, 2022; Zilio et al, 2021), although these approaches come with their own disadvantages and confounds. We have previously shown that neural timescales estimated from fMRI data in anesthetized nonhuman primates replicated hierarchies derived from neuronal spiking data, although they did not perfectly match (Manea et al, 2022).…”
Section: Discussionmentioning
confidence: 99%